U.S. Tech Hardware Stock News

Wondering if Hamilton Lane is attractively priced at around US$104.48, or if the market is asking too much for the shares right now? This article walks through that question step by step so you can judge the valuation for yourself. The stock has seen a 2.7% decline over the last 7 days, a 20.7% decline over the last 30 days, and a 23.5% decline year to date, while the 1 year return sits at a 24.3% decline and the 3 year and 5 year returns are 66.4% and 29.0% respectively. Those mixed results...

In February 2026, Structure Therapeutics Inc. reported fourth-quarter 2025 results showing net income of US$33 million, compared with a net loss of US$36.48 million a year earlier. On the same day, the company also filed a US$235.64 million shelf registration for 3,541,890 American Depositary Shares tied to an employee stock plan, signaling preparations for potential future capital needs. We’ll now explore how this shift to quarterly profitability, alongside the new shelf registration,...

Event context and recent price moves Fidelity National Financial (FNF) has recently seen a 2.1% one day decline, adding to a 4.5% pullback over the past week and a steeper slide over the past month and past 3 months. In this context, the stock now sits at $48.40, with trailing 1 year total return at a 16.2% decline and year to date performance also in negative territory. This may prompt investors to revisit how current pricing lines up with fundamentals. See our latest analysis for Fidelity...

Why Victoria's Secret stock is in focus after earnings and guidance Victoria's Secret (VSCO) is back in the spotlight after releasing quarterly results that exceeded earnings forecasts and paired strong sales with confident guidance for the coming quarter and full year 2026. The update has given investors fresh numbers to weigh, as the company outlines expectations for demand while also facing questions around profitability trends and ongoing decisions about its non core digital and styling...

Uranium Energy (UEC) has posted Q2 2026 revenue of US$20.2 million, with a basic EPS loss of US$0.03 and net income loss of US$13.9 million, providing a clear snapshot of where the business stands today. Over recent quarters, the company has reported revenue between US$0 and US$49.75 million while basic EPS has ranged from a loss of US$0.02 to a loss of US$0.07. This gives investors a wide view of how the top line and per-share results have shifted through different periods. With forecasts...

If you are wondering whether Western Digital's current share price still offers value after a big run, this article will walk through what the numbers are really saying about the stock. Western Digital recently closed at US$266.22, with a 6.2% return over the last 7 days, a 5.8% decline over 30 days, a 41.8% return year to date, and a very large 1-year gain of more than 5x. Recent headlines around Western Digital have focused on its position in data storage and memory solutions and how...

LifeMD (LFMD) has wrapped up FY 2025 with Q4 revenue of about US$46.9 million and basic EPS of around a US$0.04 loss, alongside trailing twelve month revenue of roughly US$194.1 million and basic EPS of about a US$0.32 loss. Over the past few reported periods, revenue has moved from US$64.3 million in Q4 2024 to US$65.7 million in Q1 2025, then US$61.1 million in Q2, US$60.2 million in Q3 and US$46.9 million in Q4. Quarterly EPS shifted from roughly a US$0.02 loss in Q4 2024 to a small profit...

Mosaic (MOS) is back in the spotlight as law firms review potential fiduciary duty issues tied to a federal probe into alleged fertilizer price fixing, raising fresh questions about legal risk and longer term shareholder exposure. See our latest analysis for Mosaic. At a share price of US$26.48, Mosaic has seen a 7.41% 1 month share price decline after legal headlines and mixed sentiment following its recent earnings report, even though the 90 day share price return of 11.49% and 1 year total...

Domino's Pizza (DPZ) is back in focus after reporting strong fourth quarter results, with global retail sales growth, positive U.S. same store sales, and a 15% dividend increase catching investor attention. See our latest analysis for Domino's Pizza. Even with the latest quarterly update and dividend increase, Domino's recent share price performance has been mixed. The 1 month share price return is 1.43%, and the 1 year total shareholder return reflects a 5.49% decline. However, the 3 year...

Prelude Therapeutics (PRLD) has just posted its FY 2025 numbers, with Q4 revenue of US$5.6 million, a basic EPS loss of US$0.21, and net income excluding extra items showing a loss of US$16.5 million. Over recent quarters the company has seen revenue move from US$4 million in Q4 2024 to US$6.5 million in Q3 2025 before landing at US$5.6 million in Q4 2025, while basic EPS has ranged from a loss of US$0.38 in Q4 2024 to a peak quarterly loss of US$0.42 in early 2025 and then US$0.21 in the...

AT&T (NYSE:T) has announced a US$250b U.S. network investment initiative tied to the 150th anniversary of the telephone. The plan targets fiber, 5G, wireless, and satellite expansion, along with workforce development and AI-focused upskilling. The company also plans new public safety and network security efforts, as well as public private collaborations across all regions. For you as an investor, this marks one of the largest infrastructure commitments ever announced by AT&T, a core player...

Wondering whether Merck's current share price really reflects its value, or if there is still room on the table for long term investors? Merck's stock closed at US$117.09 recently, with a 2.3% decline over the last 7 days and a 4.0% decline over 30 days, although the shares show returns of 10.0% year to date and 28.3% over the last year. Recent headlines around Merck have kept attention on its pipeline and broader pharmaceutical footprint. This helps frame how investors think about future...

Aurinia Pharmaceuticals (AUPH) just paired a strong 2025 earnings release with fresh 2026 guidance, outlining expectations for total revenue of US$315 million to US$325 million and net product sales of US$305 million to US$315 million. See our latest analysis for Aurinia Pharmaceuticals. At a share price of US$14.80, Aurinia’s recent 1 day share price return of 2.99% and 7 day share price return of 4.59% follow the 1 year total shareholder return of 78.53%. This comes even though the 90 day...

In early 2026, FedEx faced scrutiny after US customers reported unexpectedly high tariff-related fees on relatively low-value imports, while the company also reported stronger-than-expected earnings and raised its fiscal-year outlook supported by cost-cutting initiatives. This combination of legal disputes over tariff billing practices and improving profitability from efficiency measures highlights the operational and regulatory crosscurrents shaping FedEx’s business today. With FedEx’s...

If you are wondering whether Rocket Lab's current share price still makes sense after such a strong run, you are not alone. This article is going to focus squarely on what you are paying versus what you are getting. The stock closed at US$68.93, with returns of a 1.7% decline over 7 days, a 4.7% decline over 30 days, a 9.3% decline year to date and 286.6% over 1 year. The 3 year return is very large and the 5 year return is also very large, which naturally raises questions about how much...

BlackRock CEO Larry Fink is warning that new tariffs could add to inflation pressures and raise everyday costs for Americans. Fink is urging households to reassess retirement savings plans and not rely only on Social Security benefits. He is encouraging Americans to seek professional financial advice to prepare for potentially higher long term living costs. For investors watching NYSE:BLK, these comments come as the stock trades at $967.36, with a 3 year return of 62.8% and a 5 year return...

In early March 2026, Teva Pharmaceutical Industries’ CEO Richard D. Francis used a series of major healthcare conferences in the US and UK to outline the company’s “Pivot to Growth” strategy, emphasizing innovation, biosimilars expansion, and a new financing partnership with Blackstone to accelerate product development. The company’s plan to introduce an innovative product roughly every 18 months through the 2030s, including expanded indications for AUSTEDO, UZEDY, olanzapine, and AJOVY,...

In early March 2026, Core Scientific, Inc. and the Cadillac Formula 1 Team announced a multi-year global partnership naming Core Scientific as Official Data Center Partner, with the company guiding the team’s secure, scalable, high-density data hub at its new Indianapolis headquarters and supporting race-critical simulation, engineering and manufacturing workloads across U.S. and U.K. operations. Beyond branding on the Cadillac Formula 1 cars, this collaboration highlights Core Scientific’s...

Chevron (CVX) is back in focus as crude prices sit near historic highs, lifted by the Iran conflict, disruptions in the Strait of Hormuz, and OPEC+ cuts, while its Venezuela expansion adds another source of attention. See our latest analysis for Chevron. Those geopolitics driven oil swings are showing up in Chevron’s chart, with a 23.0% 90 day share price return and 19.5% year to date gain. The 5 year total shareholder return of 113.1% points to substantial long run value creation. If you are...

If you are wondering whether M&T Bank at around US$204 a share is still offering value after a strong run, you are not alone. This article is designed to help you assess what that price really represents. The stock has pulled back recently, with an approximate 6.8% decline over the last 7 days and 14.2% over the last 30 days, while still showing a 22.8% return over 1 year and 77.1% over 3 years. Recent coverage around US regional banks has kept attention on balance sheet strength, credit...

JPMorgan Chase (NYSE:JPM) CEO Jamie Dimon and the bank's analysts have issued fresh warnings about underappreciated economic and geopolitical risks. The commentary highlights concerns about inflation surprises, asset price exuberance, and rising market volatility tied to the Iran conflict and higher oil prices. Dimon has compared current risk taking to conditions seen before 2008, signaling a shift toward a more cautious market outlook from the bank's leadership. For you as an investor,...

Arq (ARQ) has just posted its FY 2025 numbers, with Q4 total revenue of US$29.4 million, a basic EPS loss of US$1.20, and a net loss of US$50.0 million. This frames a year where the trailing twelve month revenue sat at US$120.3 million and EPS on that basis was a loss of US$1.27. Over the past six quarters, quarterly revenue has ranged from US$27.0 million to US$35.1 million, while basic EPS has moved between a small profit of US$0.0049 and a loss of US$1.20. This sets up a picture of...

Microchip Technology has expanded its Trust Platform with the TA101 TrustFLEX secure authentication IC and TA101 TrustMANAGER key management service, targeting cybersecurity and compliance needs across industrial and automotive markets. By pairing hardware-based authentication with cloud key lifecycle and firmware update services, the launch aims to simplify meeting emerging regulations such as CRA, IEC 62443, ISO/SAE 21434 and UNECE WP.29 for customers building connected equipment and...

United Natural Foods (UNFI) has just posted Q2 2026 results, with revenue of US$7.9b and basic EPS of US$0.33 on net income of US$20 million. The company has seen quarterly revenue move from US$8.2b in Q2 2025 to US$7.9b in Q2 2026, while basic EPS has shifted from a loss of US$0.05 to a profit of US$0.33 over the same period. This sets up a story where investors are weighing a still loss making trailing twelve month picture against signs of improving margins in the latest quarter. See our...